Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Malignant Lymphoma

  Free Subscription


1 Am J Hematol
3 Blood
1 BMC Cancer
1 Bone Marrow Transplant
3 Br J Haematol
2 Cancer
1 Leuk Lymphoma
1 Mod Pathol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Hematol

  1. HELBER MJ, Moore JE, Williams AM, Meacham PJ, et al
    Ibrutinib Therapy for Lymphoplasmacytic Lymphoma.
    Am J Hematol. 2017 May 24. doi: 10.1002/ajh.24795.
    PubMed     Text format    


  2. GILL K
    CD5-negative mantle cell lymphoma of the breast.
    Blood. 2017;129:2950.
    PubMed     Text format    

  3. SCHMIDT J, Ramis-Zaldivar JE, Nadeu F, Gonzalez-Farre B, et al
    Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation.
    Blood. 2017 May 22. pii: blood-2017-03-776278. doi: 10.1182/blood-2017-03-776278
    PubMed     Text format     Abstract available

  4. BALSAS P, Palomero J, Eguileor A, Rodriguez ML, et al
    SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.
    Blood. 2017 May 22. pii: blood-2017-04-776740. doi: 10.1182/blood-2017-04-776740
    PubMed     Text format     Abstract available

    BMC Cancer

  5. LISENKO K, Dingeldein G, Cremer M, Kriegsmann M, et al
    Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.
    BMC Cancer. 2017;17:359.
    PubMed     Text format     Abstract available

    Bone Marrow Transplant

  6. BENTO L, Boumendil A, Finel H, Le Gouill S, et al
    Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.
    Bone Marrow Transplant. 2017 May 22. doi: 10.1038/bmt.2017.
    PubMed     Text format     Abstract available

    Br J Haematol

  7. CHEN RW, Li H, Bernstein SH, Kahwash S, et al
    RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106.
    Br J Haematol. 2017;176:759-769.
    PubMed     Text format     Abstract available

  8. BECH RS, Nielsen KL, Larsen TS, Bentzen HH, et al
    Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma.
    Br J Haematol. 2017 May 23. doi: 10.1111/bjh.14775.
    PubMed     Text format    

  9. TAO L, Clarke CA, Rosenberg AS, Advani RH, et al
    Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.
    Br J Haematol. 2017 May 25. doi: 10.1111/bjh.14638.
    PubMed     Text format     Abstract available


  10. RAJAGOPAL R, Miles GCP, Kotecha RS
    High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for pediatric primary central nervous system lymphoma in first complete remission.
    Cancer. 2017 May 23. doi: 10.1002/cncr.30768.
    PubMed     Text format    

  11. OLSZEWSKI AJ, Fallah J, Castillo JJ
    Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: Analysis of the National Cancer Data Base.
    Cancer. 2016 Jun 23. doi: 10.1002/cncr.30112.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  12. FAN Y, Zhang Y, Yang Z, Ying Z, et al
    Evaluating early interim fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with the SUVmax-liver-based interpretation for predicting the outcome in diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2017 May 23:1-9. doi: 10.1080/10428194.2016.1277384.
    PubMed     Text format     Abstract available

    Mod Pathol

  13. GAO J, Behdad A, Ji P, Wolniak KL, et al
    EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.
    Mod Pathol. 2017 May 26. doi: 10.1038/modpathol.2017.
    PubMed     Text format     Abstract available

    PLoS One

  14. YUAN T, Zhang F, Yao QM, Liu YX, et al
    Weekly versus biweekly bortezomib given in patients with indolent non-Hodgkin lymphoma: A meta-analysis.
    PLoS One. 2017;12:e0177950.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.